Clinical presentation is complex and often involves multi-system congestion. Early identification and standardized clinical care are essential for improving prognosis. Diagnosis of this disease requires a combination of clinical presentation, imaging inspection, laboratory testing and pathological activation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of H. L.
accompanied by treatment requires individualized development, typically including multidimensional management, including drug therapy, rehabilitation interventions, and regular follow-up visits. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat blood tumour diseases have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adjusted in a timely manner according to changing conditions.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of HL accompanied by Wuliyu. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.